Journal of Clinical Endocrinology & Metabolism, Vol 81, 1979-1983, Copyright © 1996 by Endocrine Society

ARTICLES

Molecular scanning of the insulin receptor gene in women with polycystic ovarian syndrome

JA Talbot, EJ Bicknell, M Rajkhowa, A Krook, S O'Rahilly and RN Clayton
Department of Medicine, School of Postgraduate Medicine, Keele University, North Staffordshire Hospital Centre, Stoke-on-Trent, United Kingdom.

Polycystic ovary syndrome (PCOS) is a common disorder characterized by chronic anovulation and infertility, hyperandrogenaemia, and frequently insulin resistance. This study investigated whether mutations in the insulin receptor gene could explain the insulin resistance in subjects with PCOS. From a total of 108 women with PCOS, a subgroup of 24 were selected on the criteria of being in the upper quartile for insulin resistance as assessed by fasting serum insulin, insulin area under the curve following 75 g oral glucose tolerance test, and endogenous glucose disposal as a measure of insulin sensitivity. An additional five normal women were also investigated. The entire coding region of the insulin receptor gene, comprising of 22 exons, was amplified by the PCR using genomic DNA and then subjected to single-stranded conformation polymorphism (SSCP) analysis to screen for single-base DNA sequence changes. DNA sequencing revealed that SSCP variants were detected in regions encompassing exons 3, 6-8, 11, 13, 15, 17, and 22. SSCP variants in regions of exons 3, 6, 7, 11, 15 and 22 were caused by nucleotide substitutions within intronic regions flanking the exon. The considerable variation seen in the 5' intron of exon 3 was found to be caused by variation in the number of (ATTT, 8-11) and (TC, 10-13) short sequence repeats. SSCP variants in exons 8 (Asp519, Ala523), 13 (Asn 838), and 17 (Tyr984, His1058) were caused by known silent polymorphisms. Southern blotting experiments excluded major gene deletions, insertions, or rearrangements. We conclude that insulin resistance in subjects with PCOS is not commonly a consequence of missense or nonsense mutations in the insulin receptor gene.

This article has been cited by other articles:

				C. Vollmert, S. Hahn, C. Lamina, C. Huth, M. Kolz, A. Schopfer-Wendels, K. Mann, F. Bongardt, J. C. Mueller, F. Kronenberg, et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E836 - E844. [Abstract] [Full Text] [PDF]

				A. Gonzalez, M.E. Saez, M.J. Aragon, J.J. Galan, P. Vettori, L. Molina, C. Rubio, L.M. Real, A. Ruiz, and R. Ramirez-Lorca Specific haplotypes of the CALPAIN-5 gene are associated with polycystic ovary syndrome Hum. Reprod., April 1, 2006; 21(4): 943 - 951. [Abstract] [Full Text] [PDF]

				L. Jin, X.-M. Zhu, Q. Luo, Y. Qian, F. Jin, and H.-F. Huang A novel SNP at exon 17 of INSR is associated with decreased insulin sensitivity in Chinese women with PCOS Mol. Hum. Reprod., March 1, 2006; 12(3): 151 - 155. [Abstract] [Full Text] [PDF]

				H. F. Escobar-Morreale, M. Luque-Ramirez, and J. L. San Millan The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome Endocr. Rev., April 1, 2005; 26(2): 251 - 282. [Abstract] [Full Text] [PDF]

				H-W. Yen, A.J. Jakimiuk, I. Munir, and D.A. Magoffin Selective alterations in insulin receptor substrates-1, -2 and -4 in theca but not granulosa cells from polycystic ovaries Mol. Hum. Reprod., July 1, 2004; 10(7): 473 - 479. [Abstract] [Full Text] [PDF]

				I. Munir, H.-W. Yen, D. H. Geller, D. Torbati, R. M. Bierden, S. R. Weitsman, S. K. Agarwal, and D. A. Magoffin Insulin Augmentation of 17{alpha}-Hydroxylase Activity Is Mediated by Phosphatidyl Inositol 3-Kinase But Not Extracellular Signal-Regulated Kinase-1/2 in Human Ovarian Theca Cells Endocrinology, January 1, 2004; 145(1): 175 - 183. [Abstract] [Full Text] [PDF]

				A. Gonzalez, E. Abril, A. Roca, M. J. Aragon, M. J. Figueroa, P. Velarde, R. Ruiz, O. Fayez, J. J. Galan, J. A. Herreros, et al. Specific CAPN10 Gene Haplotypes Influence the Clinical Profile of Polycystic Ovary Patients J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5529 - 5536. [Abstract] [Full Text] [PDF]

				A. Gonzalez, E. Abril, A. Roca, M. J. Aragon, M. J. Figueroa, P. Velarde, J. L. Royo, L. M. Real, and A. Ruiz CAPN10 Alleles Are Associated with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3971 - 3976. [Abstract] [Full Text] [PDF]

				S. B. Seminara and W. F. Crowley Jr. Genetic Approaches to Unraveling Reproductive Disorders: Examples of Bedside to Bench Research in the Genomic Era Endocr. Rev., June 1, 2002; 23(3): 382 - 392. [Abstract] [Full Text] [PDF]

				S. A. El Mkadem, C. Lautier, F. Macari, N. Molinari, P. Lefebvre, E. Renard, J. C. Gris, G. Cros, J. P. Daures, J. Bringer, et al. Role of Allelic Variants Gly972Arg of IRS-1 and Gly1057Asp of IRS-2 in Moderate-to-Severe Insulin Resistance of Women With Polycystic Ovary Syndrome Diabetes, September 1, 2001; 50(9): 2164 - 2168. [Abstract] [Full Text] [PDF]

				W.X. Liao, A.C. Roy, and S.C. Ng Preliminary investigation of follistatin gene mutations in women with polycystic ovary syndrome Mol. Hum. Reprod., July 1, 2000; 6(7): 587 - 590. [Abstract] [Full Text] [PDF]

				L. Poretsky, N. A. Cataldo, Z. Rosenwaks, and L. C. Giudice The Insulin-Related Ovarian Regulatory System in Health and Disease Endocr. Rev., August 1, 1999; 20(4): 535 - 582. [Abstract] [Full Text] [PDF]

				M. Urbanek, R. S. Legro, D. A. Driscoll, R. Azziz, D. A. Ehrmann, R. J. Norman, J. F. Strauss III, R. S. Spielman, and A. Dunaif Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin PNAS, July 20, 1999; 96(15): 8573 - 8578. [Abstract] [Full Text] [PDF]

				J. F. Strauss III and A. Dunaif Molecular Mysteries of Polycystic Ovary Syndrome Mol. Endocrinol., June 1, 1999; 13(6): 800 - 805. [Full Text]

				A. Dunaif Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis Endocr. Rev., December 1, 1997; 18(6): 774 - 800. [Abstract] [Full Text]